SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-12-054945
Filing Date
2012-11-29
Accepted
2012-11-29 16:24:55
Documents
2
Period of Report
2012-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4742
2 POA DOCUMENT poa.txt EX-24.3_445999 3964
  Complete submission text file 0001209191-12-054945.txt   10062
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Issuer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MILLER LLOYD I III (Reporting) CIK: 0000949119 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33560 | Film No.: 121232094